Annual Operating Expenses
$173.76 M
-$44.77 M-20.49%
31 December 2023
Summary:
Gossamer Bio annual total operating expenses is currently $173.76 million, with the most recent change of -$44.77 million (-20.49%) on 31 December 2023. During the last 3 years, it has fallen by -$36.82 million (-17.49%). GOSS annual operating expenses is now -20.49% below its all-time high of $218.53 million, reached on 31 December 2022.GOSS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$43.40 M
-$356.00 K-0.81%
30 September 2024
Summary:
Gossamer Bio quarterly total operating expenses is currently $43.40 million, with the most recent change of -$356.00 thousand (-0.81%) on 30 September 2024. Over the past year, it has increased by +$2.91 million (+7.18%). GOSS quarterly operating expenses is now -22.51% below its all-time high of $56.01 million, reached on 30 September 2022.GOSS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GOSS Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.5% | +7.2% |
| 3 y3 years | -17.5% | -22.0% |
| 5 y5 years | +74.9% | -13.2% |
GOSS Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.5% | at low | -22.5% | +11.2% |
| 5 y | 5 years | -20.5% | +74.9% | -22.5% | +11.2% |
| alltime | all time | -20.5% | >+9999.0% | -22.5% | +5116.2% |
Gossamer Bio Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.40 M(-0.8%) |
| June 2024 | - | $43.76 M(+4.3%) |
| Mar 2024 | - | $41.96 M(+7.5%) |
| Dec 2023 | $173.76 M(-20.5%) | $39.03 M(-3.6%) |
| Sept 2023 | - | $40.49 M(-12.5%) |
| June 2023 | - | $46.28 M(-3.4%) |
| Mar 2023 | - | $47.93 M(-11.8%) |
| Dec 2022 | $218.53 M(+1.1%) | $54.34 M(-3.0%) |
| Sept 2022 | - | $56.01 M(+4.0%) |
| June 2022 | - | $53.86 M(-0.9%) |
| Mar 2022 | - | $54.32 M(+5.2%) |
| Dec 2021 | $216.05 M | $51.65 M(-7.2%) |
| Sept 2021 | - | $55.65 M(+0.1%) |
| June 2021 | - | $55.58 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $53.17 M(-2.9%) |
| Dec 2020 | $210.58 M(+15.4%) | $54.79 M(+2.8%) |
| Sept 2020 | - | $53.29 M(+5.9%) |
| June 2020 | - | $50.34 M(-3.5%) |
| Mar 2020 | - | $52.16 M(-3.7%) |
| Dec 2019 | $182.54 M(+83.8%) | $54.19 M(+8.4%) |
| Sept 2019 | - | $49.99 M(+10.2%) |
| June 2019 | - | $45.35 M(+37.4%) |
| Mar 2019 | - | $33.02 M(-17.1%) |
| Dec 2018 | $99.33 M(+8515.3%) | $39.81 M(-4.7%) |
| Sept 2018 | - | $41.76 M(+233.1%) |
| June 2018 | - | $12.54 M(+139.8%) |
| Mar 2018 | - | $5.23 M(+528.4%) |
| Dec 2017 | $1.15 M(+1289.2%) | $832.00 K |
| Dec 2016 | $83.00 K | - |
FAQ
- What is Gossamer Bio annual total operating expenses?
- What is the all time high annual operating expenses for Gossamer Bio?
- What is Gossamer Bio annual operating expenses year-on-year change?
- What is Gossamer Bio quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Gossamer Bio?
- What is Gossamer Bio quarterly operating expenses year-on-year change?
What is Gossamer Bio annual total operating expenses?
The current annual operating expenses of GOSS is $173.76 M
What is the all time high annual operating expenses for Gossamer Bio?
Gossamer Bio all-time high annual total operating expenses is $218.53 M
What is Gossamer Bio annual operating expenses year-on-year change?
Over the past year, GOSS annual total operating expenses has changed by -$44.77 M (-20.49%)
What is Gossamer Bio quarterly total operating expenses?
The current quarterly operating expenses of GOSS is $43.40 M
What is the all time high quarterly operating expenses for Gossamer Bio?
Gossamer Bio all-time high quarterly total operating expenses is $56.01 M
What is Gossamer Bio quarterly operating expenses year-on-year change?
Over the past year, GOSS quarterly total operating expenses has changed by +$2.91 M (+7.18%)